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Romanian Journal of Diabetes Nutrition & Metabolic Diseases / Vol. 24 / no. 4 / 2017 patient behavior -contributing to the development of above mentioned pathologies [3, 4] . There are also many important cardiovascular risk factors that result from the lifestyle of the patient: hypertension, obesity, dyslipidemia, smoking, sedentariness [5] .
Framingham score is an algorithm obtained from a complex study that estimates the individual risk of each patient to develop a cardiovascular event over the next 10 years depending on certain parameters (age, smoking, total cholesterol, HDL-cholesterol, systolic blood pressure) [6, 7] .
Our study aimed to evaluate the crossassociations between the components of the metabolic syndrome, cardiovascular risk (evaluated by the Framingham risk score), diabetes-related biological parameters and chronic kidney disease in patients hospitalized due to poor metabolic control.
Material and methods

Study design and patients
In this cross-sectional study, we enrolled 218 patients with type 2 diabetes (T2DM), admitted in the Diabetes Clinic of the "Pius Brinzeu" Emergency Hospital Timisoara, according to a consecutive-case populationbased principle. All these patients were hospitalized due to the presence of a metabolic imbalance which required hospitalization to be corrected.
Patients enrolled in the study were aged between 30 and 84 years, mean 629.5 years. More than a half were males (58.7%), with a mean age of 61.08 (9.945), 95% CI (59.34; 62.82), while 41.3% were females, mean age of 63.30 (8.735), 95% CI (59.34; 62.82).
The population was divided into the following age strata, 30-44, 45-59, 60-74 and 75-84 years. Participants of the strata 60-74 represent more than a half of the patients (52.3%), both in men and women (males: 47.7%, females: 58.9%). Patients in the strata 30-44 years represented the lowest proportions in both sexes (males: 4.7%, females: 1.1%).
Anthropometric, clinical and biological data
During the hospitalization, objective data such as: height, weight, BMI calculation were collected. Blood pressure values were measured initially and during hospitalization. A complete set of biochemical explorations (HbA1c, albumin-to-creatinin ratio, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, serum creatinine) was performed for each patient.
Statistical analysis
Data was analyzed and collected using SPSS v.17 (SPPS Inc, Chicago, IL, USA) and is presented as mean and standard deviation (continuous variables having Gaussian distribution), median and interquartile range (IQR -in case of continuous variables without Gaussian Distribution) respectively percentages and absolute frequency for categorical variables. The variable's distribution type was evaluated using the Shapiro-Wilk test and for homoscedasticity using Levene's test.
The statistical tests used were: the Student's t-test (differences in means, variables with Gaussian distribution), Mann-Whitney U test (medians, non-Gaussian populations) respectively Pearson's Chi-Square and Fisher's exact test for proportions.
The correlation between studied variables was evaluated using Spearman's rank sum correlation coefficient (non-Gaussian distributed variables), its statistical significance being assessed using the t-distribution score test.
A p-value of 0.05 was considered as the threshold for statistical significance, and a confidence level of 0.95 was considered for estimating intervals.
Results
As a result of the evaluation of the baseline clinical and biochemical characteristics of the patients included in the study, we have obtained the results presented in Table 1 . 
Diabetes Duration
The study sample included both patients with newly diagnosed diabetes as well as patients with diabetes duration longer than 30 years (Table 2) . In the age stratum of 60-74 years, most of the patients (29.8%) had a diabetes duration in the interval between 10 and 15 years, while in the other diabetes duration categories, namely, less than 5 years, 5-10 years and 15-20 years were equally distributed proportions, 20.0%.
Considering the BMI, we observed that half of the patients (49.1%) were obese and 31.7% of patients were overweight, while 7.8% presented extreme obesity (BMI >40 kg/m 2 ). Moreover, most of the overweight (84.1%), obese (87.9%), and extreme obese (88.2%) patients had suboptimal values of HbA1c.
Hypertension
The proportion of patients with high blood pressure was almost 50% for both males (systolic: 44.5%, diastolic: 46.7%) and females (systolic: 46.7%, diastolic: 40.4%). Most of the patients with hypertension were in the age group 60-74 years (systolic: 56.6%, diastolic: 54.0%). For males, the highest proportions of patients found to be hypertensive were in the age group, 45-59 years (systolic: 43.9%, diastolic: 45.1%) and 60-74 years (systolic: 45.6%, diastolic: 45.1%), while for females, most of the hypertensive patients were in the age group 60-74 years (systolic: 71.4%, diastolic: 66.7%).
Hyperlipidemia
We observed that 13.8% of patients presented high and very high LDL cholesterol levels (160-189 mg/dL and more than 189 mg/dL), while 32.2% of patients had borderline high LDL cholesterol levels (130-159 mg/dL) as shown in Table 3 . The proportions of patients included in the five LDL cholesterol levels were equally distributed between males and females. In the diabetes duration interval of 10-15 years were most of the patients in the borderline high and high LDL cholesterol levels (130-150 mg/dL and 160-189 mg/dL), 17.5% and 10.5%, respectively. We observed that all the patients with very high LDL cholesterol levels (more than 189 mg/dL) presented a suboptimal diabetes control. At the same time, almost all the patients (95.7%) with high LDL cholesterol levels (160-189 mg/dL) had HbA1c below 7%. Moreover, we observed that high levels of LDL cholesterol are significantly correlated with high levels of HbA1c (r = 0.141, p < 0.05). Most of the female patients (90%) presented low levels of HDLc (<50 mg/dl), being exposed to an increased risk of CHD. Moreover, most of them (85.2%) had suboptimal HbA1c levels. We observed that high levels of HbA1c are significantly correlated with low levels of HDL cholesterol (r = 0.134, p < 0.05).
We observed that 32.6% of patients had high and very high triglycerides levels (200-499 mg/dL and 500 mg/dL or above), while 16.5% presented borderline high triglycerides levels (150 to 199 mg/dL). Most of the patients with high and very high triglycerides levels were in the age stratum of 60-74 years, 54.0% and 75.0%, respectively. We observed that all the patients with very high triglycerides levels (500 mg/dL or above) presented a suboptimal diabetes control. At the same time, most of the patients (79.4%) with high triglycerides levels (200-499 mg/dL) and almost all the patients (91.7%) with borderline high triglycerides levels (150 to 199 mg/dL) had HbA1c below 7%. Moreover, we observed that high levels of triglycerides are significantly correlated with high levels of HbA1c (r =. 0.193, p < 0.01). Also, we observed that high levels of HbA1c are significantly correlated with high levels of VLDL cholesterol (r = 0.160, p < 0.05). 
Chronic kidney disease (CKD)
Considering the measured glomerular filtration rate (GFR), we observed that 12.4% of patients were placed in CKD stage G3b (30-44 ml/min and 15-29 ml/min), while 0.9% of patients were included in the G5 stage (<15 ml/min) (KDIGO2012 classification). We observed that all the patients with kidney failure presented a suboptimal diabetes management. At the same time, most of the patients with G3b kidney failure (30-44 ml/min), i.e. 84.3%, and G4 stage (15-29 ml/min), i.e., 94.4% had HbA1c below 7%.
When considering albumin-to-creatinin ratio (ACR), we observed that almost half of the patients presented microalbuminuria (30-300 mg/g), so a moderate CKD stage (A2). Additionally, a percent of 13.8% presented a severely increased risk of developing CKD. We observed that most of the patients at moderately increased and severely increased risk of CKD presented a suboptimal diabetes management, 85.3% and 80.0%, respectively. Additionally, computing the prognosis of CKD based on GFR and Albuminuria categories (KDIGO2012), we observed that a percent of 20.0% were at high risk of CKD, while 13.3% were at very high risk of CKD. Figure 1 presents the CKD risk groups based on both GFR and ACR values.
Figure 1. Prognosis of CKD risk level based on GFR and ACR values (KDIGO2012). CKD -Chronic Kidney Disease; GFR -Glomerular Filtration Rate; ACRAlbumin/creatinine ratio.
Treatment
Diabetes treatment included metformin (76.1% of patients), sulfonylurea (23.1% of patients), DPP-4 inhibitors (16.1% of patients), GLP-1receptor agonists (6.9% of patients), and two types of insulin, basal (50.5% of patients) and rapid (25.7% of patients). In addition, more than a half of the patients followed a treatment including hypertension medications: ACE inhibitors/ARBs (58.7%), beta-blockers (61.9%), and diuretics (57.6%), while calcium channel blockers were administrated to 11.5% of patients. Moreover, 67.9% of patients followed a treatment including cholesterol-lowering drugs, such as statins (Table 4) . 
Risk of cardiovascular disease (CVD)
We assessed the risk score of developing heart disease or having a heart attack by computing the Framingham 10-year risk estimation. For male patients, the Framingham scores ranged between 6 and 24, mean 18.883.275, while the scores for female patients were slightly lower, ranging from 10 to 23, mean 18.4732.581.
We observed that the Framingham scores highly correlated with GFR for both men and women, r = -419, p < 0.0001, and r = -0.391, p < 0.0001, respectively. At the same time, we observed significant differences between the score values of patients with and without systolic and diastolic hypertension, for both male, systolic: Mann-Whitney U test (U = 7.662, p < 0.001), diastolic: Mann-Whitney U test (U = 6.999, p < 0.01), and female patients, systolic: Mann-Whitney U test (U = 8.169, p < 0.001), Figures 3 and 4 include the graphical representation of the correlation of the Framingham risk score and age, and Framingham risk score level stratified by age for female and male patients, respectively. We observed that CVD risk increases as age increases, when considering both the risk score and risk level for both men and women.
Discussion
The increase in the number of diabetic patients highlights the importance for developing new strategies for prevention, early diagnosis and management of disease complications. This is a global problem that concerns both the patient and the medical staff, as well as the general population, given the exorbitant costs generated by DM [8, 9] .
Screening of the disease is deficient, although there are concrete tests that can be carried out in this regard. This is why at the time of the diagnosis one third of the diabetic patients already have associated complications [10] .
Over the course of the last decade, many scores have been proposed to accurately determine the risk of patients developing the disease and its complications, in particular cardiovascular events [11, 12] .
Framingham risk score provides the individual probability of each patient to develop a cardiovascular event over the next 10 years depending on certain parameters (age, smoking, total cholesterol, HDL-cholesterol, systolic blood pressure) [9] . The initial version thought in calculating this score was upgraded and uses more specific parameters (age range, hypertension treatment, smoking, total cholesterol, and diabetes) [13] .
Conclusions
The value of body mass index was positively correlated with an increased level of HbA1c, a significant percentage of the patients being overweight or obese. Half of our study cohort had associated hypertension, the proportion between male and female being equal.
Suboptimal values of HbA1c were correlated with increased LDL-cholesterol levels, high triglycerides and with the presence of low to severe CKD.
As a final conclusion, Framingham risk score revealed that CVD risk increases as age increases in patients with DM, when considering both the risk score and risk level for both men and women. For female patients Framingham risk score is slightly lower (ranged between 10 to 23) than for male patients (ranged between 6 and 24).
